Fate Therapeutics Inc FATE:NASDAQ

Last Price$18.81Cboe Real-Time Last Sale as of 3:32PM ET 8/20/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.18(0.95%)
Bid (Size)$18.81 (200)
Ask (Size)$18.84 (200)
Day Low / High$18.50 - 19.02
Volume278.4 K

Significant Insider Selling in Shares of Fate Therapeutics (FATE) Continues

10:16PM ET 1/30/2019 MT Newswires
A SEC filing today disclosed a substantial insider sale of Fate Therapeutics shares as -- Dr Amir Nashat, Director -- disposed of 90,000 shares in the company having a market value of approximately $1,272,753. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 689,483 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 779,483 shares and have averaged 389,742 shares per transaction over this time period.

The number of insider buy/sell trades at Fate Therapeutics is greater than the 324 peer company average over the last 90-day period. The Bio Therapeutic Drugs peer group saw 454 buy/sell trades during this period for an average of 1.4 transactions per company. The number of shares per buy/sell trade for Fate Therapeutics insiders was also higher. Within the peer group there were 121,212,090 shares purchased and 16,629,905 shares sold with company insiders purchasing 399,169 shares on average.

For the purpose of evaluating significant insider buying and selling all trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data sourced to compose and write this story.